» Articles » PMID: 31245252

Brief Novel Therapies for PTSD: Written Exposure Therapy

Overview
Specialty Psychiatry
Date 2019 Jun 28
PMID 31245252
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Written Exposure Therapy (WET) is a 5-session exposure-based intervention for the treatment of posttraumatic stress disorder (PTSD). WET was developed through a series of systematic evaluations of the expressive writing procedure. It is an efficient intervention, requiring limited patient and therapist time and no between-session assignments. The treatment results in statistically and clinically significant symptom change among individuals, including veterans, with PTSD.

Recent Findings: WET has been shown to be non-inferior to Cognitive Processing Therapy (CPT), a more intensive form of PTSD treatment. Additionally, WET resulted in substantially lower rates of treatment dropout compared to CPT (6% versus 39%). Moderator analyses of the rate of symptom change during treatment indicated that WET performed equally well for participants regardless of age, gender, comorbid depression, or estimated full scale IQ.

Summary: WET represents a viable option for the efficacious, brief treatment of PTSD and may have significant strengths compared to other manualized psychotherapeutic approaches.

Citing Articles

Narrative-based autobiographical memory interventions for PTSD: a meta-analysis of randomized controlled trials.

Raeder R, Clayton N, Boeckle M Front Psychol. 2023; 14:1215225.

PMID: 37829075 PMC: 10565228. DOI: 10.3389/fpsyg.2023.1215225.


A Systematic Review of Interventions for Prevention and Treatment of Post-Traumatic Stress Disorder Following Childbirth.

Dekel S, Papadakis J, Quagliarini B, Jagodnik K, Nandru R medRxiv. 2023; .

PMID: 37693410 PMC: 10485880. DOI: 10.1101/2023.08.17.23294230.


Expressive writing treatments to reduce PTSD symptom severity and negative alcohol-related outcomes among trauma-exposed sexual minority women and transgender/nonbinary people: Study protocol for a mixed-method pilot trial.

Scheer J, Behari K, Schwarz A, Cascalheira C, Helminen E, Pirog S Contemp Clin Trials Commun. 2023; 35:101197.

PMID: 37671246 PMC: 10475481. DOI: 10.1016/j.conctc.2023.101197.


Family-authored ICU diaries to reduce fear in patients experiencing a cardiac arrest (FAID fear): A pilot randomized controlled trial.

Cornelius T, Mendieta M, Cumella R, Lopez Veneros D, Tincher I, Agarwal S PLoS One. 2023; 18(7):e0288436.

PMID: 37498834 PMC: 10373992. DOI: 10.1371/journal.pone.0288436.


PTSD / substance use disorder comorbidity: Treatment options and public health needs.

Najavits L, Clark H, DiClemente C, Potenza M, Shaffer H, Sorensen J Curr Treat Options Psychiatry. 2022; 7(4):544-558.

PMID: 35444925 PMC: 9017717. DOI: 10.1007/s40501-020-00234-8.


References
1.
Sloan D, Lee D, Litwack S, Sawyer A, Marx B . Written exposure therapy for veterans diagnosed with PTSD: a pilot study. J Trauma Stress. 2013; 26(6):776-9. PMC: 3898035. DOI: 10.1002/jts.21858. View

2.
Pennebaker J, Beall S . Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol. 1986; 95(3):274-81. DOI: 10.1037//0021-843x.95.3.274. View

3.
Cigrang J, Rauch S, Mintz J, Brundige A, Mitchell J, Najera E . Moving effective treatment for posttraumatic stress disorder to primary care: A randomized controlled trial with active duty military. Fam Syst Health. 2017; 35(4):450-462. DOI: 10.1037/fsh0000315. View

4.
Sloan D, Marx B, Epstein E . Further examination of the exposure model underlying the efficacy of written emotional disclosure. J Consult Clin Psychol. 2005; 73(3):549-54. DOI: 10.1037/0022-006X.73.3.549. View

5.
Weathers F, Keane T, Davidson J . Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001; 13(3):132-56. DOI: 10.1002/da.1029. View